Evaluation of Bacteremia Epidemiology During the COVID Period in One French University Hospital

• Sponsor: Centre Hospitalier Universitaire de Nice (Other)
• Overall Status: Completed
• CT.gov ID: NCT05640349
• Collaborator: (none)
• Enrollment: 4,200
• Location: 1
• Actual Duration (Months): 5.5
• Patients Per Site Per Month: 760.9

Study Details

Study Description

Brief Summary

The main objective of this retrospective cohort is to evaluate the impact of the first epidemic wave during lockdown on bacteremia epidemiology in one French University Hospital.

Condition or Disease	Intervention/Treatment	Phase
Bacteremia; Catheter-Related Infections	Biological: Positive blood culture

Study Design

• Study Type: Observational
• Actual Enrollment: 4200 participants
• Observational Model: Cohort
• Time Perspective: Retrospective
• Official Title: Evaluation of Bacteremia Epidemiology During the COVID Period in One French University Hospital
• Actual Study Start Date: Apr 15, 2022
• Actual Primary Completion Date: Sep 30, 2022
• Actual Study Completion Date: Sep 30, 2022

Arms and Interventions

Arm	Intervention/Treatment
Case Patients with positive blood culture recorded at the microbiology laboratory of University Hospital of Nice during the Covid-19 Pandemic lockdown (between 23/03/2020 and 24/05/2020).	Biological: Positive blood culture; Positive blood culture recorded at the microbiology laboratory of University Hospital of Nic
Control Patients with positive blood culture recorded at the microbiology laboratory of University Hospital of Nice between 23/03/2019 and 24/05/2019.	Biological: Positive blood culture; Positive blood culture recorded at the microbiology laboratory of University Hospital of Nic

Outcome Measures

Primary Outcome Measures

1. Epidemiology of bacteriemia,catheter-related infection and contamination [Day 0]

   Describe and compare the incidence and epidemiology of hospital-diagnosed bacteriemia, catheter-related infection and contamination

Secondary Outcome Measures

1. Characterization of community bacteremia [Day 0]

2. Determined therapeutic actions [Day 0]

   Anticipate the diagnostic and therapeutic actions to be taken for future epidemics

Eligibility Criteria

Criteria

• Ages Eligible for Study: N/A and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

o Inclusion criteria : Patients with positive blood culture recorded at the microbiology laboratory of University Hospital of Nice Aged 18 years

o Exclusion criteria : Patients with negative blood culture recorded at the microbiology laboratory of University Hospital of Nice

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	CHU de Nice	Nice		France	06001

Sponsors and Collaborators

• Centre Hospitalier Universitaire de Nice

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Centre Hospitalier Universitaire de Nice
• ClinicalTrials.gov Identifier: NCT05640349
• Other Study ID Numbers: 22Infectio02
• First Posted: Dec 7, 2022
• Last Update Posted: Dec 7, 2022
• Last Verified: Dec 1, 2022

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Bacteremia; Catheter-Related Infections

Study Results

No Results Posted as of Dec 7, 2022